Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
J Am Coll Emerg Physicians Open ; 4(2): e12924, 2023 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-36936059
3.
Behav Pharmacol ; 29(8): 745-761, 2018 12.
Artigo em Inglês | MEDLINE | ID: mdl-30394882

RESUMO

The ability to decide advantageously among options that vary in both their risks and rewards is critical for survival and well-being. Previous work shows that some forms of risky decision-making are robustly modulated by monoamine signaling, but it is less clear how monoamine signaling modulates decision-making under risk of explicit punishment. The goal of these experiments was to determine how this form of decision-making is modulated by dopamine, serotonin, and norepinephrine signaling, using a task in which rats choose between a small, 'safe' food reward and a large food reward associated with variable risks of punishment. Preference for the large, risky reward (risk-taking) was reduced by administration of a D2/3 dopamine receptor agonist (bromocriptine) and a selective D2 agonist (sumanirole). The selective D3 agonist PD128907 appeared to attenuate reward discrimination abilities but did not affect risk-taking per se. In contrast, drugs targeting serotonergic and noradrenergic signaling had few if any effects on choice behavior. These data suggest that in contrast to other forms of risky decision-making, decision-making under risk of punishment is selectively modulated by dopamine signaling, predominantly through D2 receptors.


Assuntos
Monoaminas Biogênicas/metabolismo , Tomada de Decisões/fisiologia , Punição , Assunção de Riscos , Inibidores da Captação Adrenérgica/farmacologia , Animais , Cloridrato de Atomoxetina/farmacologia , Condicionamento Operante/efeitos dos fármacos , Condicionamento Operante/fisiologia , Tomada de Decisões/efeitos dos fármacos , Dopaminérgicos/farmacologia , Relação Dose-Resposta a Droga , Locomoção/efeitos dos fármacos , Masculino , Modelos Animais , Distribuição Aleatória , Ratos , Ratos Long-Evans , Serotoninérgicos/farmacologia
4.
Behav Brain Res ; 321: 130-136, 2017 03 15.
Artigo em Inglês | MEDLINE | ID: mdl-28057530

RESUMO

Chronic administration of cocaine can cause pronounced and enduring cognitive alterations such as increases in impulsive choice. Chronic cocaine can also result in enhanced dopamine (DA) release in the nucleus accumbens (NAc) in response to reward-related cues. It is possible that this enhanced DA release in the NAc is a mechanism by which cocaine increases impulsive choice. To date, however, the specific role of DA in the NAc in impulsive choice is unclear. To begin to address this, rats received acute microinjections of the indirect DA agonist amphetamine directly into the NAc prior to testing in a delay discounting task in which rats chose between a small, immediate and a large, delayed food reward. When delays to the large reward increased within test sessions, amphetamine increased choice of the large reward. When delays decreased within test sessions, however, amphetamine decreased choice of the large reward. These findings suggest that, rather than specifically mediating impulsive choice, DA neurotransmission in the NAc is necessary for flexible adaptation of choice strategies in the presence of shifting reward contingencies. These results further indicate that enhancements in NAc DA release likely do not account for lasting increases in impulsive choice caused by chronic cocaine.


Assuntos
Anfetamina/farmacologia , Desvalorização pelo Atraso/efeitos dos fármacos , Dopaminérgicos/farmacologia , Núcleo Accumbens/efeitos dos fármacos , Análise de Variância , Animais , Desvalorização pelo Atraso/fisiologia , Dopamina/metabolismo , Relação Dose-Resposta a Droga , Comportamento Impulsivo/efeitos dos fármacos , Comportamento Impulsivo/fisiologia , Masculino , Microinjeções , Núcleo Accumbens/metabolismo , Testes Psicológicos , Ratos Long-Evans , Recompensa
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...